Xiaoli Duan
Cancer detection and diagnosis have been revolutionized by advancements in nanotechnology and surface-enhanced spectroscopy techniques. This article explores the application of Surface-Enhanced Photoluminescence (SEPL) on nanostructured silver substrates for the immunosensing of cancer markers. We delve into the principles behind SEPL, the fabrication of nanostructured silver substrates, and the integration of antibodies for selective cancer marker detection. Additionally, we discuss the potential implications of this technology in early cancer diagnosis and personalized medicine. Cancer remains one of the most pressing health challenges globally, with early detection playing a crucial role in improving patient outcomes. Conventional cancer diagnostics often rely on invasive procedures and may lack sensitivity and specificity. However, emerging technologies, such as surface-enhanced spectroscopy, offer promising avenues for sensitive and selective cancer detection. In this article, we focus on the application of Surface Enhanced Photoluminescence (SEPL) on nanostructured silver substrates for the immunosensing of cancer markers.
PDFShare this article
Journal of Clinical & Medical Genomics received 391 citations as per Google Scholar report
